Litcius/Paper detail

E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2

Qianfan Liu, Chunzhuo Song, Junjun Li, Meng Liu, Liyue Fu, Jiuliang Jiang, Zhirui Zeng, Haitao Zhu

2022Medical Oncology23 citationsDOI

Topics & Concepts

GemcitabinePancreatic cancerCancer researchCell cycleDeoxycytidine kinaseBiologyCancerCancer cellCell growthDeoxycytidineInternal medicineOncologyMedicineBiochemistryPancreatic and Hepatic Oncology ResearchCancer-related Molecular PathwaysCholangiocarcinoma and Gallbladder Cancer Studies
E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2 | Litcius